Adding ibrutinib to frontline therapy improves outcomes in transplant-eligible patients with MCL.

David Killock

Published in: Nature reviews. Clinical oncology (2024)

Keyphrases

stem cells
chronic lymphocytic leukemia
type diabetes
adipose tissue
bone marrow
glycemic control